A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

BACKGROUND: Stereotactic ablative body radiotherapy (SABR) is emerging as a non-invasive method for precision irradiation of lung tumours. However, the ideal dose/fractionation schedule is not yet known. The primary purpose of this study is to assess safety and efficacy profile of single and multi-f...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Siva, Shankar, Kron, Tomas, Bressel, Mathias, Haas, Marion, Mai, Tao, Vinod, Shalini, Sasso, Giuseppe, Wong, Wenchang, Le, Hien, Eade, Thomas, Hardcastle, Nicholas, Chesson, Brent, Pham, Daniel, Høyer, Morten, Montgomery, Rebecca, Ball, David
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778366/
https://ncbi.nlm.nih.gov/pubmed/26944262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2227-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items